FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:2096-2097 December 30, 1999 Number 27 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Norton, J. A. PubMed Citation

To the Editor: Norton et al. (Aug. 26 issue)¹ report 10-year surgical-cure rates of 34 percent in 123 patients with sporadic gastrinomas and 0 percent in 28 patients with multiple endocrine neoplasia type 1. The authors' objective was limited to the elimination of discoverable gastrinoma, as determined by measurements of serum gastrin, secretin tests, and imaging studies. A preferable objective would have been to eliminate reliably the aggressive peptic ulcer disease and diarrhea that characterize the Zollinger–Ellison syndrome by suppressing acid secretion with the use of proton-pump–inhibitor therapy.²

Norton et al. provide little information on morbidity or the functional outcome . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.